| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.835 | 3.808 | 2.561 | 2.708 | 1.897 | 1.675 | 2.365 | 2.048 | 1.213 | 0 |
| Total Income - EUR | 2.835 | 3.808 | 2.561 | 2.708 | 1.897 | 1.675 | 2.365 | 2.048 | 1.213 | 0 |
| Total Expenses - EUR | 491 | 431 | 454 | 363 | 341 | 438 | 347 | 348 | 366 | 480 |
| Gross Profit/Loss - EUR | 2.343 | 3.377 | 2.107 | 2.345 | 1.556 | 1.237 | 2.018 | 1.700 | 847 | -480 |
| Net Profit/Loss - EUR | 2.258 | 3.262 | 2.030 | 2.263 | 1.499 | 1.187 | 1.947 | 1.638 | 711 | -480 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medoviv Alpha S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.495 | 8.173 | 7.804 | 7.443 | 7.099 | 6.769 | 6.428 | 6.257 | 6.046 | 5.823 |
| Current Assets | 3.474 | 4.700 | 4.556 | 4.990 | 4.351 | 4.174 | 5.049 | 4.948 | 4.290 | 3.163 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 558 | 59 |
| Cash | 3.470 | 4.698 | 4.554 | 4.988 | 4.349 | 4.172 | 5.046 | 4.946 | 3.732 | 3.105 |
| Shareholders Funds | 7.620 | 8.569 | 7.247 | 7.385 | 6.521 | 6.114 | 6.765 | 6.471 | 5.529 | 4.311 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.349 | 4.305 | 5.113 | 5.048 | 4.929 | 4.830 | 4.712 | 4.733 | 4.808 | 4.675 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Medoviv Alpha S.r.l.